Market research
000520.KO Samil Pharmaceutical Co.,Ltd
KO KRW Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 173B
- P/E ratio
- Not available
- Analyst target
- 10000
- Dividend yield
- Not available
- Beta
- 0.34
Community
Investor discussion
1 comment
Sign in to join the 000520.KO discussion.
5 years, 6 months ago
Samil Pharmaceutical Co.,Ltd is currently in a long term downtrend where the price is trading 7.3% below its 200 day moving average.
From a valuation standpoint, the stock is 88.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.0.
Samil Pharmaceutical Co.,Ltd's total revenue sank by 0.4% to $30B since the same quarter in the previous year.
Its net income has increased by 42.4% to $-545M since the same quarter in the previous year.
Finally, its free cash flow fell by 146.9% to $-4B since the same quarter in the previous year.
Based on the above factors, Samil Pharmaceutical Co.,Ltd gets an overall score of 2/5.